Search results
Repertoire® Immune Medicines and Bristol Myers Squibb Announce Multi-Year Strategic Collaboration to...
CBS 47 Fresno· 6 days agoRepertoire® Immune Medicines, a biotechnology company pioneering the discovery and development of programmable T cell targeted immune medicines, announced today that it has entered a multi-year ...
After 'reset,' Flagship startup lands $1.8B Bristol Myers Squibb deal - Boston Business Journal
The Business Journals· 6 days agoTorben Straight Nissen took over the reins of Repertoire Immune Medicines at the tail end of 2022,...
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 7 days agoGlobal Drone Market to Surpass USD 166.70 Billion by 2031 | Skyquest Technology PR Newswire WESTFORD, Mass., April 29, 2024 WESTFORD, Mass., April 29, 2024 ...
Bruker Q1 Revenues Rise 5 Percent, Missing Analysts' Estimate
GenomeWeb News· 3 days agoBruker on Thursday reported a 5 percent year-over-year increase in first quarter revenues, with gains across all of its business segments but missing analysts' expectations. Separately, Bruker ...
Senators Slam UnitedHealth’s C.E.O. Over Cyberattack
New York Times· 4 days agoSeveral lawmakers questioned whether the company had become so large — with tentacles in every aspect of the nation’s medical care — that the effects of...
Squares + Streets initiative bringing an exciting opportunity to Dorchester
Dorchester Reporter· 5 days agoBill Walczak’s April 16 column, “Change moves at the speed of trust,” takes issue with Mayor Wu’s...
As Israel’s campaign in Gaza faces international scrutiny, New York native recalls horror of Oct. 7
WAMC Northeast Public Radio· 5 days agoCollege campuses around the U.S. are seeing intense protests over Israel’s war in Gaza, which shows no signs of ending more than six months after Hamas’ attacks. At the same time, one survivor ...